Dow Jones
37.775,38 +22,07 (+0,06%) Nasdaq
15.601,50 -81,87 (-0,52%) Nikkei 225
37.440,62 -639,08 (-1,68%) EUR/USD
1,0641 -0,0006 (-0,05%) Bitcoin EUR
59.388,19 +2.013,84 (+3,51%) CMC Crypto 200
1.304,52 +418,98 (+46,95%)
Enochian BioSciences Inc (2Q5.BE)
| Chiusura precedente | 2,1550 |
| Aperto | 2,0900 |
| Denaro | 2,1250 x N/D |
| Lettera | 2,2100 x N/D |
| Min-Max giorno | 2,0800 - 2,2350 |
| Intervallo di 52 settimane | 0,3660 - 4,8800 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | N/D |
| Prossima data utili | 10 mag 2024 - 14 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireAvram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Miller will join its Board of Directors. Beyond this board position, Mr. Miller will also take on an advisory role, contributing to the company's strategy and business development efforts. Renovaro Biosciences has recently signed a definitive agreement to combine with GEDiCube, a UK-based medical AI comp
- GlobeNewswire
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors with short life expectancy, is pleased to announce the appointment of Leni Boeren and Ruud Hendriks as Independent Directors. Renovaro recently announced a definitive agreement to combine with the advanced AI Company GEDi Cube Intl Ltd. GEDiCube intends to rebrand as Renovaro AI, as announced on Se
- GlobeNewswire
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to CombineLOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB) Dear Shareholders, I am writing to provide you with an update on our recent news of signing a definitive agreement to combine with GEDiCube (GEDiCube Press Release) (Renovaro Press Release) and to share our vision for the promising future of our newly combined company if you, as shareholders, approve the agreement. As we embark o
